Complement activation in the brain after experimental intracerebral hemorrhage.

OBJECT Brain edema formation following intracerebral hemorrhage (ICH) appears to be partly related to erythrocyte lysis and hemoglobin release. Erythrocyte lysis may be mediated by the complement cascade, which then triggers parenchymal injury. In this study the authors examine whether the complement cascade is activated after ICH and whether inhibition of complement attenuates brain edema around the hematoma. METHODS This study was divided into three parts. In the first part, 100 microl of autologous blood was infused into the rats' right basal ganglia, and the animals were killed at 24 and 72 hours after intracerebral infusion. Their brains were tested for complement factors C9, C3d, and clusterin (a naturally occurring complement inhibitor) by using immunohistochemical analysis. In the second part of the study, the rats were killed at 24 or 72 hours after injection of 100 microl of blood. The C9 and clusterin proteins were quantitated using Western blot analysis. In the third part, the rats received either 100 microl of blood or 100 microl of blood plus 10 microg of N-acetylheparin (a complement activation inhibitor). Then they were killed 24 or 72 hours later for measurement of brain water and ion contents. It was demonstrated on Western blot analysis that there had been a sixfold increase in C9 around the hematoma 24 hours after the infusion of 100 microl of autologous blood. Marked perihematomal C9 immunoreactivity was detected at 72 hours. Clusterin also increased after ICH and was expressed in neurons 72 hours later. The addition of N-acetylheparin significantly reduced brain edema formation in the ipsilateral basal ganglia at 24 hours (78.5 +/- 0.5% compared with 81.6 +/- 0.8% in control animals, p < 0.001) and at 72 hours (80.9 +/- 2.2% compared with 83.6 +/- 0.9% in control animals, p < 0.05) after ICH. CONCLUSIONS It was found that ICH causes complement activation in the brain. Activation of complement and the formation of membrane attack complex contributes to brain edema formation after ICH. Blocking the complement cascade could be an important step in the therapy for ICH.

[1]  Yuan Zhang,et al.  Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.

[2]  R. Keep,et al.  Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. , 1999, Stroke.

[3]  R. Keep,et al.  Comparison of cerebral blood flow and injury following intracerebral and subdural hematoma in the rat , 1999, Brain Research.

[4]  James L. Park,et al.  N-Acetylheparin Pretreatment Reduces Infarct Size in the Rabbit , 1999, Pharmacology.

[5]  D. Hanley,et al.  No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage , 1999, Neurology.

[6]  R. Keep,et al.  Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. , 1998, Journal of neurosurgery.

[7]  J. Broderick,et al.  Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. , 1998, Stroke.

[8]  J. Silver,et al.  Complement Depletion Reduces Macrophage Infiltration and Activation during Wallerian Degeneration and Axonal Regeneration , 1998, The Journal of Neuroscience.

[9]  P. Giannakopoulos,et al.  Possible neuroprotective role of clusterin in Alzheimer’s disease: a quantitative immunocytochemical study , 1998, Acta Neuropathologica.

[10]  H. Sarau,et al.  Complement Depletion Improves Neurological Function in Cerebral Ischemia , 1998, Brain Research Bulletin.

[11]  M. Pappolla,et al.  Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis , 1998, Acta Neuropathologica.

[12]  M. Kirschfink,et al.  Controlling the complement system in inflammation. , 1997, Immunopharmacology.

[13]  C. C. Park,et al.  The complement membrane attack complex and the bystander effect in cerebral vasospasm. , 1997, Journal of neurosurgery.

[14]  Simard Jm,et al.  The complement membrane attack complex and the bystander effect in cerebral vasospasm. , 1997 .

[15]  R. Buist,et al.  Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates. , 1996, Stroke.

[16]  A. Paetau,et al.  Complement activation in the central nervous system following blood–brain barrier damage in man , 1996, Annals of neurology.

[17]  P. May,et al.  Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity , 1996 .

[18]  M. Svensson,et al.  Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat. , 1996, Journal of neurosurgery.

[19]  M. Bednar,et al.  Systemic complement depletion inhibits experimental cerebral vasospasm. , 1996, Neurosurgery.

[20]  R. Keep,et al.  Edema from intracerebral hemorrhage: the role of thrombin. , 1996, Journal of neurosurgery.

[21]  J T Hoff,et al.  Intracerebral infusion of thrombin as a cause of brain edema. , 1995, Journal of neurosurgery.

[22]  B. Lucchesi,et al.  Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. , 1995, Cardiovascular research.

[23]  B. Lucchesi,et al.  Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. , 1994, Circulation research.

[24]  J. Weiler,et al.  Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. , 1994, Immunopharmacology.

[25]  C. Finch,et al.  Clusterin (SGP‐2): A multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain , 1994, The Journal of comparative neurology.

[26]  B. Lucchesi Complement activation, neutrophils, and oxygen radicals in reperfusion injury. , 1993, Stroke.

[27]  F. Micheli,et al.  Wallenberg's syndrome secondary to bullet injury of the vertebral artery. , 1993, Stroke.

[28]  J. Weiler,et al.  Heparin and modified heparin inhibit complement activation in vivo. , 1992, Journal of immunology.

[29]  B. Lucchesi Complement, neutrophils and oxygen radicals in myocardial-ischemia reperfusion injury , 1992 .

[30]  P. Mcgeer,et al.  Activation of the classical complement pathway in brain tissue of Alzheimer patients , 1989, Neuroscience Letters.

[31]  B. Kristensen,et al.  Immune complexes and complement activation following rupture of intracranial saccular aneurysms. , 1987, Journal of neurosurgery.

[32]  S. Bhakdi,et al.  On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum. , 1984, Journal of immunology.

[33]  W. Tourtellotte,et al.  Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis. , 1980, Clinical immunology and immunopathology.

[34]  E. E. Ecker,et al.  Anticomplementary Power of Heparin , 1929 .